As a spin-off startup of National Taipei University of Technology, the company's product is a polysaccharide synergistic cleaning, lubricating, and conditioning solution. By incorporating a patented polysaccharide composition formula, it resolves the cumbersome operations faced by orthokeratology (Ortho-K) lens and rigid gas permeable (RGP) contact lens wearers, who otherwise must daily use conditioning solutions and weekly use protein removal agents A and B, artificial tears, rewetting drops, and various other products. Experiments have proven that this product can reduce protein adsorption on lenses by 30% to 45%. Furthermore, verified through an exclusive ophthalmic friction platform, it can reduce the friction coefficient of lenses by 50% compared to commercially available products, helping to enhance the wearer's comfort. The product is currently in the pilot production stage and is expected to obtain certification and launch on the market in 2024. In addition, Biolumula Biomedical Co., Ltd. also focuses on developing biomedical lubrication formulations, with core technologies that can be applied to ophthalmology, orthopedics, and dentistry.
(The content above was translated by AI.)